Measuring Consumer Exposure Confounds US FDA’s Evaluation Of Cannabinoid Safety In Supplements

Acting commissioner Woodcock reminds manufacturers and marketers that a consumer’s exposure to cannabidiol and other cannabinoids likely comes from using multiple products daily. “How do you control exposure of people in a nonprescription setting?”